Retatrutide (Reta) — Research Peptide
10-vial box (10 × vials)

Retatrutide (also written Reta; research code LY3437943) is a synthetic peptide studied as a triple agonist of the GLP-1, GIP, and glucagon receptors. In vendor language it is often called a “GLP-3” analogue. That label is informal. It is not an approved drug name and does not mean this product is licensed as a medicine.

This listing is a 10-box: ten separately sealed research vials in one pack, intended for laboratory and in-vitro research only.

Intended use
For qualified research use only (RUO). Suitable for in-vitro assays, analytical work, and other non-clinical laboratory studies of incretin and glucagon-pathway peptides.

Not for human or animal use.
Not a medicine, supplement, food, or cosmetic.
Not for diagnosis, treatment, cure, or prevention of any disease.

Research context
Published research has examined retatrutide as a multi-receptor peptide at GLP-1, GIP, and glucagon targets. This product is supplied as a research material so laboratories can study those pathways under their own protocols. No clinical outcome is promised. No dosing, reconstitution, or administration guidance for living subjects is provided.

Pack contents
Format:** 10-box
Contents:** 10 vials of retatrutide research peptide
Use:** one sealed research unit per vial; box is sold as a 10-count laboratory pack

Vial size, fill amount, and stated purity should match the batch COA shipped with the order. Do not use a vial if the seal is broken or the label does not match the COA.

Quality documentation
Each batch should be supported by a certificate of analysis (identity, purity, and related quality data). Research use depends on that paperwork. If a COA is missing, do not put the material into a study.

Handling and storage (laboratory)
Store as stated on the vial and COA (typically cool, dry, protected from light).
Limit freeze–thaw cycles.
Use appropriate PPE and standard laboratory controls for peptides.